n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, October 19th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

True Leaf Medicine International Ltd. (TRLFF)

Stockhouse, Investing, and MarketWatch reported on True Leaf Medicine International Ltd. (TRLFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

True Leaf Medicine International Ltd., via its wholly-owned subsidiary 'True Leaf Pet, Inc.', has entered the international pet industry with a line of hemp-focused pet supplements in the U.S., Canada, and Europe. The Company’s other subsidiary is ‘True Leaf Medicine, Inc.’. OTCQB-listed, True Leaf Medicine International is headquartered in Vancouver, British Columbia.

True Leaf Pet established in 2015 to pioneer and market hemp-focused products for the pet industry. The Company’s Pet segment markets only legal hemp-seed based pet products online, as well as in stores throughout the U.S., Canada, Europe, and New Zealand.

True Leaf Medicine came on the scene in 2013 to become a licensed producer of medical cannabis. It has received approval from the Government of Canada to construct its facilities.

The Company has filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer of medical cannabis via 'True Leaf Medicine'. True Leaf has passed through the preliminary and enhanced screening process of Health Canada's review.

In late September, True Leaf Medicine International announced that it acquired an option to purchase the 40 acres of land, which encompasses its facility in Lumby, B.C., via its wholly-owned subsidiary True Leaf Medicine, Inc. This Option is exercisable until December 31, 2017. The facility will have a production capacity of greater than 6,000 kilograms of dried cannabis annually. This is once phase one of the project is completed.

Mr. Darcy Bomford, True Leaf Medicine International’s Chief Executive Officer, said, "This is a milestone for True Leaf. This property gives us the capacity to expand to meet the increased demand that is widely expected. With government approvals, the size of this site could allow us to build a 1,000,000 square foot facility and produce more than 125,000 kilograms of cannabis."

This week, True Leaf Medicine International announced that it secured DTC eligibility for its common shares from The Depository Trust Company (DTC) effective October 10, 2017. The DTC is a subsidiary of the Depository Trust & Clearing Corporation (DTCC). The DTC manages the electronic clearing and settlement for the bulk of publicly traded equities and other securities in the United States.

True Leaf Medicine International Ltd. (TRLFF), closed Thursday's trading session at $0.5787, down 2.89%, on 18,817 volume with 11 trades. The average volume for the last 60 days is 17,220 and the stock's 52-week low/high is $0.16/$0.7134.

InterCloud Systems, Inc. (ICLD)

Stock Onion, Stock Tips Network, Buzz Stocks, BUYINS.NET, Greenbackers, Jason Bond, RedChip, Wealthpire Inc., INO Market Report, GreatStockPix, Street Insider, Microcapmillionaires, PennyPro, Promotion Stock Secrets, Marketbeat, Broad Street, StocksImpossible, OTCBB Journal, PennyStockProphet, Penny Pick Finders, Planet Penny Stocks, Hit and Run Candle Sticks, and Investing Futures reported earlier on InterCloud Systems, Inc. (ICLD), and today are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 2006, InterCloud Systems, Inc. is a top provider of cloud networking orchestration and automation solutions and services. The Company provides the modern-day Information Technology (IT) and network solutions to the enterprise markets by way of cloud computing and professional services. InterCloud provides cloud services (SaaS, PaaS, and IaaS), professional consulting, data solutions, and maintenance services.

The Company’s mission is to enable carriers to expedite the deployment of Virtualized Network and IT Services. InterCloud Systems has its corporate office in Shrewsbury, New Jersey. The Company’s shares trade on the OTC Markets Group’s OTCQB.

InterCloud is a foremost provider of cloud networking orchestration and automation for Software Defined Networking (SDN) and Network Function Virtualization (NFV) cloud environments to the telecommunications service provider (carrier) and corporate enterprise markets. Its cloud solutions provide enterprise and service-provider customers the opportunity to adopt an operational expense model through outsourcing cloud deployment and management to InterCloud Systems.

InterCloud’s products and solutions include NFVGrid – NFVO Management & Analytics Platform. This is a full scale next generation networking platform for virtualized network functions. NFVGrid is proprietary IP. Nonetheless, it fully embraces Open Source.

This past August, InterCloud Systems announced that it entered into a contract with Tekmark Global Solutions for its automated provisioning and management software system for multi-location and multi data-center networks – NFVgrid SD-WAN. The SD-WAN solution provides functions for fully secure, encrypted connection of remote offices and data centers without the requirement for IT technicians’ onsite or truck roll requirements. Tekmark is a multi-national, New Jersey headquartered IT professional services company.

Mr. Guy DelGrande, Tekmark Global Solutions’ Chief Executive Officer, stated: “The implementation of NFVgrid SD-WAN will allow Tekmark to manage its wide area network more efficiently. A lot of network configurations, management and monitoring functions that were traditionally handled manually are now automated utilizing NFVgrid SD-WAN.”

In addition, in August, InterCloud Systems announced that it was awarded a fiber build contract in California with a tier 1 service provider. It is Company Management’s belief that this contract may result in revenues of $5 million or greater over the life of the contract.

InterCloud Systems, Inc. (ICLD), closed Thursday's trading session at $0.0072, down 5.26%, on 4,915,498 volume with 110 trades. The average volume for the last 60 days is 10,098,373 and the stock's 52-week low/high is $0.0065/$0.394.

Zoompass Holdings, Inc. (ZPAS)

MarketWatch and InvestorsHub reported on Zoompass Holdings, Inc. (ZPAS) and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Zoompass Holdings, Inc. is a leading financial services technology enterprise headquartered in Toronto, Ontario. The Company is a financial platform provider. It has divisions in physical prepaid cards, financing enablement, as well as mobility products. In January 2017, Zoompass received approval from FINRA (the Financial Industry Regulatory Authority, Inc.) to change the name from UVIC, Inc. to Zoompass Holdings, Inc. The Company's ticker was changed to ZPAS from UVVC. Zoompass Holdings’ shares trade on the OTC Markets Group’s OTCQB.

The Company provides powerful financial services, virtually, through one of the most advanced platforms available. Zoompass provides businesses and governments tailored solutions to help digitize their financial transactions. The Company enables businesses to provide their customers with a number of open loop card choices. These include gift cards, incentive cards, check replacement cards, as well as online virtual card accounts.

Zommpass’ platform drives banking independence, personal financial accountability, and new revenue opportunities for small and large businesses. In the card sector, Zoompass provides complete program management services for a wide assortment of open loop Visa® and MasterCard® prepaid and virtual card accounts. Its mobile device division helps carriers and mobile device manufacturers integrate the financial platform technology into their offerings.

Zoompass can support clients’ program management requirements, provide turnkey program management services including program concept, card design, card submission and approval, client portal design and development, administration management, reporting and customer service support.

The Company also provides advanced mobile technology. This permits businesses to provide their customers with a white label mobile wallet solution, such as Zoompass, with the ability to manage their card balances, bill pay, transfer funds, and perform card to card money transfers in real time using their mobile devices. The Zoompass Platform and the Prepaid Card Solution can be combined with the Company’s Mobile Money technology to transform a business.

Recently, Zoompass announced the confirmation of a strategic alliance with Advanced Credit Technologies, Inc. and its CyberloQ FRAUD prevention technology. Cyberloq provides one of the most integrated fraud mitigation systems available to the prepaid and credit card sector. Cyberloq has a multi-layer authentication approach to security.

Cyberloq can eliminate most fraud by way of an innovative check-in process using three levels of authentication. The combination of a card spending algorithm, geo-fencing, and smartphone authentication on a per transaction basis enables Cyberloq customers to virtually eliminate card fraud.

Zoompass Holdings, Inc. (ZPAS), closed Thursday's trading session at $0.64, up 1.43%, on 20,442 volume with 18 trades. The average volume for the last 60 days is 104,688 and the stock's 52-week low/high is $0.25/$3.75.

Worlds, Inc. (WDDD)

TopPennyStockMovers and Barchart reported on Worlds, Inc. (WDDD), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Worlds, Inc. is a foremost intellectual property (IP) developer and licensee of patents related to 3D online virtual worlds. The Company has a portfolio of 10 U.S. patents for multi-server technology for 3D applications. Worlds has developed patented 3D technology that provides 3D multi-user environments, called "virtual worlds." The Company developed software and related technology for the creation of 3D Internet environments covering massively multiplayer online role-playing games (MMORPG).

Established in 1994, Worlds has its headquarters in Brookline, Massachusetts. The Company previously went by the name Worlds.com, Inc. It changed its corporate name to Worlds, Inc. in February of 2011.

The Company designs and develops software, content, and related technology for the creation of interactive 3D Internet Websites. Worlds’ plan is to monetize its patent portfolio through enforcement, licensing, and royalties of its patented technologies.

The design of Worlds’ 3D Internet sites is to enable visitation by users through providing them with online communities featuring different content and interactive capabilities. The Company’s technology is used in varied applications. These include virtual meeting places, 3D e-commerce stores, and virtual classrooms

The design of its technologies is for large-scale communities of simultaneous online users, who interact within online interactive 3D virtual worlds. These 3D communities permit visitors to interact with each other, teleport throughout the Worlds environment, and participate in shared experiences.

The virtual worlds have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video, and e-commerce. Worlds partners with existing content providers that have strong brands as well as an existing following. Moreover, the Company encourages individuals to create their own virtual spaces, communities, and innovative Avatars with user-friendly tools.

The Company’s technology includes WorldsShaper, a compositing 3D building tool that integrates pre-existing or custom content; and WorldsServer, a scalable software to control and operate on-line virtual communities. Its technology also includes WorldsBrowser to access the 3D environments; and WorldsPlayer to view and experience multi-user, interactive technology. Additionally, its technology includes Worlds Gamma Libraries to compose sample worlds, textures, models, avatars, actions, sensors, sounds, motion sequences, and other behaviors.

Worlds announced in December of last year that the U.S. Patent & Trademark Office (USPTO) validated six patent claims by Worlds following Patent Trial and Appeal Board (PTAB) review of World's influential technology. This technology has been central to the development of massively multiplayer online role-playing gaming (MMORPG) into a multi-billion-dollar industry.

Worlds, Inc. (WDDD), closed Thursday's trading session at $0.0345, up 7.48%, on 275,200 volume with 23 trades. The average volume for the last 60 days is 217,218 and the stock's 52-week low/high is $0.019/$0.0649.

Advanced BioMedical Technologies, Inc. (ABMT)

Zacks reported earlier on Advanced BioMedical Technologies, Inc. (ABMT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Advanced BioMedical Technologies, Inc. manufactures and distributes advanced impedance controlled micro-current instruments. It has treated greater than 15,000 patients during the past 28 years. The Company is a leader in education, research, training, and instrument sales and works with doctors and clinicians across the United States. This includes those in Minnesota, the majority of which have an affiliation with the University of Minnesota.

Advanced BioMedical Technologies is headquartered in Eagan, Minnesota. The Company lists on the OTC Markets’ OTCQB. Advanced BioMedical Technologies is the oldest distributor of the Electro-Acuscope and Electro-Myopulse. The Company has a 6,000-square foot office complex, with 3,000 square feet dedicated as a patient care treatment center.

The Electro-Acuscope and Electro-Myopulse instruments feature the most sophisticated computerized, feedback-controlled, energy delivery, micro-current technology available today. The Company has a complete staff of qualified professionals fully trained on this pioneering technology.

Acuscope products include the Electro-Acuscope 85P (Portable); the Electro-Acuscope 80L; and the Neuroscope 230B. Myopulse products include the Electro-Myopulse 75L (Base Model) and the Electro-Myopulse 75F (used in Fermi Lab Study).

In addition, Advanced BioMedical Technologies has its La Fleur products. These include the Electro-Myopulse 75LN Premium Instrument (Myopulse, Facial and Esthetics) that was developed exclusively by the Company. Furthermore, Advanced BioMedical Technologies carries a line of Accessories.

The Electro-Myopulse measures the Bio-Impedance of the muscle tissue between the two electrodes. Likewise, this is how the current amplitude and voltage output is adjusted and controlled. The Myopulse uses a sine wave. This sine wave imitates the wave produced when a muscle first contracts.

The Electro-Acuscope monitors nerve conduction between two electrodes. This is how the current amplitude and voltage output is adjusted and controlled. The Acuscope uses a complex waveform. This waveform imitates a nerve impulse.

The design of the Electro-Acuscope 85P (Portable) instrument is for the traveling clinician or patient (with prescription). This instrument is built into a haliburtor case for safe and easy portability.

The Company’s Neuroscope 230B (Home Care Unit) is for the personal treatment of sleep, anxiety, and pain issues. The product is a personal treatment device for the person on the go. Additionally, it is as an adjunct to Acuscope and Myopulse (impedance controlled microcurrent) therapy where extended rehabilitation therapy necessitates additional treatments at home.

Advanced Biomedical Technologies supported the only peer-reviewed, published study, which proved that the Electro-Acuscope/Electro-Myopulse System could reverse radiation induced fibroses and stimulate glandular repair.

Advanced BioMedical Technologies, Inc. (ABMT), closed Thursday's trading session at $0.20, even for the day. The average volume for the last 60 days is 1,321 and the stock's 52-week low/high is $0.10/$0.21.

QS Energy, Inc. (QSEP)

RedChip reported previously on QS Energy, Inc. (QSEP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

QS Energy, Inc. is a developer of integrated technology solutions for the energy industry. The Company develops and commercializes energy efficiency technologies, which help in meeting growing international energy demands, improving the economics of oil extraction and transport, and reducing greenhouse gas emissions. QS Energy’s Intellectual Property (IP) portfolio includes 48 domestic and international patents and patents pending. These have undergone development in combination with, and exclusively licensed from, Temple University. QS Energy is based in Tomball, Texas.

QS Energy’s AOT™ (Applied Oil Technology) is a group of commercial crude oil pipeline flow assurance products designed to undergo installation at pipeline pump stations in the upstream, gathering, and midstream sectors. AOT™ is an integrated system. It improves critical operational efficiencies for pipeline operators around the world. AOT™ lowers the viscosity of unrefined oil using low wattage electrical fields (electrorheology) to improve flow while in transit through pipelines.
AOT™ is an industrial hardware system. It is completely fabricated in the United States. AOT™ technology delivers performance that can be measured in each of the areas of importance in the movement hydrocarbon stream - from reservoir to the point of sale. The Company’s AOT™ stand-alone or supplemental pipeline solutions boost flow rates; decrease power consumption; optimize flow assurance; enhance pipeline integrity; and prevent bottlenecks.

AOT has been completely prepared over the past fur years for commercial use with the collaboration of more than 30 engineering teams at 19 independent oil production and transportation entities interested in harnessing its demonstrated efficacy to boost pipeline performance and flow, drive up committed and uncommitted toll rates for pipeline operators, and decrease pipeline operating costs.

QS Energy has its new strategic plan. The core mission of this plan is to expedite market adoption of its AOT™ technology. QS Energy is seeking a partner/customer and a location where the Company can jointly develop operations under relaxed conditions of non-disclosure, permit prospects to tour an operating facility, and provide them with summary operating data for review and detailed analysis.

QS Energy announced at the end of June 2017 that it named Mr. Shannon Rasmussen as its new Vice President of Engineering. He is a key industry veteran who, along with Chief Executive Officer, Mr. Jason Lane, will help lead commercialization efforts for QS Energy's Applied Oil Technology (AOT).
Mr. Rasmussen is Co-founder and Senior Principal of energy consulting firm Citrine Energy (Colorado-headquartered). Mr. Rasmussen comes to QS Energy with almost two decades of experience in the power and oil and gas sectors. He has considerable expertise in engineering design, project and program management, construction, compliance, and quality.

QS Energy, Inc. (QSEP), closed Thursday's trading session at $0.305, down 2.40%, on 75,060 volume with 11 trades. The average volume for the last 60 days is 144,757 and the stock's 52-week low/high is $0.031/$0.32.

MRI Interventions, Inc. (MRIC)

Real Pennies, Wall Street Resources, and FeedBlitz reported previously on MRI Interventions, Inc. (MRIC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MRI Interventions, Inc. is a medical device company that develops and commercializes distinct platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Utilizing a hospital's existing MRI suite, the design of its Food and Drug Administration (FDA)-cleared and CE-marked ClearPoint® system is to enable a range of minimally invasive procedures in the brain. MRI Interventions is based in Irvine, California.

The ClearPoint® system enables real-time MRI-guided navigation for a broad array of minimally-invasive neurosurgery procedures. The platform is especially well-matched for facilitating drug delivery directly to brain tumors. The ClearPoint® system is the only navigation platform designed to allow real-time visualization during minimally-invasive neurosurgical procedures.

MRI Interventions has a co-development and co-distribution agreement with Brainlab, which a leader in software-driven medical technology, pertaining to the ClearPoint® system. Additionally, MRI Interventions is developing the ClearTrace® system in partnership with Siemens Healthcare. This is to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

ClearPoint® is an integrated system of hardware components, disposable components, as well as intuitive, menu-driven software. The ClearPoint® system provides MRI-based stereotactic guidance for the placement and operation of instruments or devices during the planning and operation of neurological procedures performed within the MRI suite. ClearPoint® procedures can be utilized with 1.5T and 3T scanners.

This past July, MRI Interventions announced that Children’s National Hospital in Washington DC performed its first case employing the ClearPoint® Neuro Navigation System. The ClearPoint System is currently being used in seven of the top ten nationally ranked Children’s Hospitals for Neurosurgery and Neurology, and also a number of other leading hospitals specializing in pediatric care. Children’s National Hospital in Washington DC is ranked number nine in the nation for pediatric neurosurgery by U.S. News and World Report.

For Q2 2017, ended June 30, 2017, MRI Interventions’ Total Revenue grew 79 percent to $2.0 million, from $1.1 million in the same period of the year prior. Gross Margin grew to 60 percent, versus 53 percent in the same period of 2016.

In Q2, the Company completed a quarterly record of 162 procedures using the ClearPoint® Neuro Navigational System. This is the ninth consecutive quarter growth in procedure volume. In addition, it completed three ClearPoint systems sales, started two new systems evaluations; and increased the install base to 50 accounts in the United States.

Earlier this month, MRI Interventions announced the appointment of Mr. Joseph Burnett as President and Chief Executive Officer (CEO) effective November 7. The Company’s current President and CEO, Mr. Frank Grillo, will continue in the role until November 6, and will serve as an Executive Advisor to MRI Interventions for a period of time afterwards.

MRI Interventions, Inc. (MRIC), closed Thursday's trading session at $2.90, up 0.69%, on 19,171 volume with 25 trades. The average volume for the last 60 days is 45,059 and the stock's 52-week low/high is $1.76/$7.40.

graphic

The QualityStocks
Company Corner

graphic
graphic

Medical Innovation Holdings, Inc. (MIHI)

The QualityStocks Daily Newsletter would like to spotlight Medical Innovation Holdings, Inc. (MIHI). Today, Medical Innovation Holdings, Inc. closed trading at $0.76, up 11.76%, on 307,831 volume with 158 trades. The stock’s average daily volume over the past 60 days is 28,100, and its 52-week low/high is $0.15/$3.99.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Medical Innovation Holdings, Inc. (MIHI), a client of NNW that owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers. The publication, titled, "Telemedicine: Reducing the Costs While Enhancing the Quality of Health Care," discusses companies decreasing the cost of health care services through the use of inventive telemedicine solutions. To view the full publication, visit: https://www.networknewswire.com/telemedicine-reducing-costs-enhancing-quality-health-care/

Medical Innovation Holdings, Inc. (MIHI), a Colorado-based publicly traded company, owns and operates strategically aligned healthcare service and product companies focused on the delivery of patient care, management services for physician offices, lab services, and pharma; and non-pharma medicines and alternatives to patients and consumers. Healthcare services are delivered and managed through the company's MSO, 3Point Care. 3Point Care uses virtual telemedicine with a unique customized software and hardware platform as a way of bringing quality medical care to rural and medically underserved areas (MUAs) of the country.

3Point Care provides personalized high-tech, high-touch telemedicine encounters that link virtual health specialty doctors with traditional primary physicians and their patients. This approach helps reduce the cost of care while enhancing the quality of care. The company's telemedicine approach is vastly different from other providers who rely on a monthly subscription to opt in the network and then require an encounter fee by the patient each and every time an on-demand physician is utilized. This approach breaks the continuum of care, relies on symptom-based diagnosis, does not accept insurance, and there is no certainty you are dealing with a licensed practitioner. In summation they are not a medical practice but a contract service to deliver virtual care. Because 3Point Care deploys doctors through an actual medical practice, there is no subscription fee. The company works with anyone and everyone that has insurance including Medicare and Medicaid. It works hand and hand with the patient's primary care physician so the continuum of care is always maintained. Part of the integrated software application enables the processing of insurance claims whereby doctors are paid for their services. This allows deductibles to be captured, allowing the patients to take advantage of medical tax deductions.

TeleLifeMd, a multi-disciplinary specialty healthcare practice with strong experience in telemedicine, is the primary deliverer of patient medical care. 3Point care has a unique and exclusive relationship with TeleLifeMD, acting as its management services organization by providing all levels of service that include scheduling, providing telemedicine hardware and software products and support, processing claims, paying all invoices and payroll incurred by TeleLifeMD, as well as any other service required to operate the practice.

BKare Diagnostics, another wholly owned subsidiary of MIHI, is tasked with delivering medical and health-related services such as laboratory testing, diagnostics, and alternative medicines primarily proven nutraceuticals. Its goal is to eventually infuse these products with 100% CBD/Hemp oil and THC-based oils to create new product categories as the law catches up with the cannabis marketplace. The opportunity to offer workable solutions that solve real health problems outside typical big pharma is very exciting for the company. It sees significant revenue opportunities in this space.

MIHI firmly believes the best way to provide access to high-quality medical care is through support and delivery of evidence-based virtual medicine, commonly known as telemedicine. With 80 million people living in rural, medically underserved areas of the nation, the company is poised to fill a glaring void in the healthcare industry by applying cutting-edge technology and time-tested business practices to deliver real-time care. Among the 16 areas of medical specialties available are cardiology, infertility, gastroenterology, pediatrics and obstetrics.

The company serves a number of constituents and stakeholders interested in reducing the cost of health care while simultaneously increasing the quality of care, improving access to health services for millions of people, and bringing value to company shareholders. Its unique platform incorporates every aspect of a telemedicine visit into a single, comprehensive package. Disclaimer

Medical Innovation Holdings, Inc. Company Blog

Medical Innovation Holdings, Inc. News:

NetworkNewsWire Announces Publication Highlighting Innovative Solutions in Telemedicine

Medical Innovation Holdings, Inc. (MIHI) is “One to Watch”

Medical Innovation Holdings, Inc. (MIHI) Announces Recruitment of Industry Veteran as COO

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.0619, up 2.82%, on 2,163,928 volume with 145 trades. The stock’s average daily volume over the past 60 days is 3,890,612, and its 52-week low/high is $0.002/$0.0995.

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring PotNetwork Holding, Inc. (POTN), a client of NNW that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. The publication, titled, "Mounting Evidence on Therapeutic Benefits of Cannabis Unleashes Tsunami," discusses numerous public companies focused on developing CBD for medicinal use. To view the full publication, visit: https://www.networknewswire.com/mounting-evidence-therapeutic-benefits-cannabis-unleashes-tsunami/

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

NetworkNewsWire Announces Publication Discussing CBD Alternatives to Traditional Medicine

PotNetwork Holding, Inc. Projects Third Quarter Revenues Will Top First Six Months Results, Based on Record Sales Volume for July and August

Exceeding $1,750,000.00 in Revenues for August, PotNetwork Holding, Inc.’s Diamond CBD Hits Highest Revenues Recorded to Date

LottoGopher Holdings Inc. (OTCQB:LTTGF) (CSE:LOTO) (FRA:2LG)

The QualityStocks Daily Newsletter would like to spotlight LottoGopher Holdings Inc. (LTTGF). Today, LottoGopher Holdings Inc. closed trading at $0.1894, up 10.70%, on 113,344 volume with 43 trades. The stock’s average daily volume over the past 60 days is 125,910 and its 52-week low/high is $0.15/$0.50.

LottoGopher Holdings Inc. (LTTGF) is a new lottery messenger service that provides its subscribers with the security of ordering and managing the legal purchase of state lottery tickets online using debit and credit cards. LottoGopher makes it simple for users to keep track of tickets and winnings. Members have exclusive access to strategies, alerts, lottery news and can play alone with a single ticket or join online public or private groups to pool winnings.

LottoGopher is transforming the lottery buying experience, which has historically meant taking the time and spending the gas money to drive to a retail location, then stand in line to buy via cash only and redeem tickets. LottoGopher's uniquely online messenger service streamlines the experience of taking a shot at the lottery and makes it much more convenient and access to electronic payment, otherwise not permitted in CA. While only California residents at this time can play Mega Millions, SuperLotto Plus and Powerball through LottoGopher.com, expansion plans are in the works to allow internet-savvy residents in 22 other states with legal lotteries to have the same advantages of purchasing tickets online.

LottoGopher also enjoys a strategic business relationship with Lottoland, ranked in the Financial Times' FT1000 Report as one of Britain's Top 30 fastest growing companies and as the second ranked gaming company in Europe. Since launching in 2013, Lottoland has rapidly become a world leader in the online lottery sector with nearly $357 million (U.S. dollars) in annual sales.

LottoGopher's currently integrated support systems include a mobile friendly platform; automated email follow-up system to capture, score and remarket to email address leads; social media listening and outreach; utilization of Google Analytics tools; one-time promotional offers across multiple platforms; main and backup credit card processing accounts; and focus on customer service.

Customers of LottoGopher pay a subscription fee to use the service, much like Netflix, Amazon Prime or Dollar Shave Club. After selecting their subscription plan, users pay the same price per ticket as if purchasing from a retail, brick-and-mortar location. LottoGopher's team then secures the selected tickets from a lottery retailer partner. User account balances are updated after a drawing, which makes it impossible for a member to "lose" a winning ticket.

The company's target market includes the 80 million U.S. consumers already buying lottery tickets who typically purchase products online. Offering a far more convenient way to play the lottery via an intuitive platform, LottoGopher is well positioned to disrupt this multi-billion dollar industry. Disclaimer

LottoGopher Holdings Inc. Blog

LottoGopher Holdings Inc. News:

NetworkNewsWire Announces Publication Harnessing the Power of Celebrity Endorsements

NetworkNewsWire Releases Exclusive Audio Interview with LottoGopher Holdings Inc.

NetworkNewsWire Announces Publication on Successful Subscription Businesses

Kootenay Zinc Corp. (CSE:ZNK) (OTCQB:KTNNF)

The QualityStocks Daily Newsletter would like to spotlight Kootenay Zinc Corp. (KTNNF). Today, Kootenay Zinc Corp. closed trading at $0.0506, up 2.64%, on 21,500 volume with 4 trades. The stock’s average daily volume over the past 60 days is 17,689, and its 52-week low/high is $0.007/$0.59.

Kootenay Zinc Corp. (KTNNF) is a mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") zinc deposits. Based in Vancouver, British Columbia, the company is ideally positioned near its primary target, the Sully Property, located 18 miles east of the world-class Sullivan Mine.

Of the 22 raw materials tracked by the Bloomberg Commodity Index, zinc was the best-performing base metal in 2016. Based on a widening global supply deficit, outlook for the commodity remains strong. As the most closely tied base metal to the Chinese economy, zinc demand and prices are expected to rise well into the year 2020, putting increased pressure on zinc supply.

For 2017, Goldman Sachs has predicted a 360,000 ton shortage of zinc, along with a subsequent rise in zinc prices to $2,500 per metric ton in the first half of the year. Zinc continues to make history in the metals exchange, driving significant interest in the market amid supply constraints in concentrates and refined metal drive prices.

Ready to claim its share of the market, Kootenay Zinc is focused on its Sully Property. It comprises 1,375 hectares and overlies rocks of similar age and origin as those which host the legendary Sullivan deposit. The Sullivan mine was discovered in 1892, and is known to be one of the world's largest SEDEX deposits. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately 300 million ounces of silver, 8 million tonnes of zinc and 8 million tonnes of lead.

Notably, geophysical data suggests that Kootenay Zinc's Sully project and Sullivan share many geological features:

  • Strata at Sully are in the same sedimentary basin as the Sullivan mine
  • The exact stratigraphic time horizon at which Sullivan formed is present at Sully
  • Filtered AeroMag anomalies coincident with Sullivan Time at Sully appear similar to Sullivan
  • Gravity anomaly at Sully indicates excess mass of comparable magnitude to Sullivan
  • Pb-Zn is present as traces in outcrop, drill core and in a soil geochemical anomaly

The squeeze in zinc supplies particularly affects China, which is both the world's largest zinc consumer and its largest producer, with 4.9 million tons of output in 2015. Chinese manufacturers are now being forced to import zinc for use in cars, household appliances, paints, rubber products and smartphones.

Zinc's rally shows no sign of slowing down in the near future, and companies that currently occupy stake in a zinc deposit find themselves in an enviable position over miners rushing to find new reserves. With its Sully Project, Kootenay Zinc could be on track to capture its share of the market, guided by a management team of mining directors and executives that currently lead some of the world's best mining companies and have been involved in world-class discoveries which sold for billions of dollars. The company's technical team includes industry experts that have worked on mega-mining projects, including the Sullivan and Voisey Bay projects. Disclaimer

Kootenay Zinc Corp. Company Blog

Kootenay Zinc Corp. News:

Sully Project - E3 Target Drilling Underway

Kootenay Zinc Corp.: Sully Project Exploration Update

NetworkNewsWire Releases Exclusive Audio Interview with Kootenay Zinc Corp. (KTNNF)

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.37, up 1.37%, on 45,973 volume with 36 trades. The stock’s average daily volume over the past 60 days is 112,097 and its 52-week low/high is $0.1701/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

NetworkNewsWire Announces Publication Highlighting Key Players in Big Pharma M&A

University of British Columbia to Perform Clinical Study on the Cardiovascular and Cognitive Health Effects of Lexaria's TurboCBD

HighCom Global Security, Inc. (HCGS)

The QualityStocks Daily Newsletter would like to spotlight HighCom Global Security, Inc. (HCGS). Today, HighCom Global Security, Inc. closed trading at $0.021, even for the day, on 50,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 33,519 and its 52-week low/high is $0.006/$0.10.

HighCom Global Security, Inc. (HCGS) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

BlastGard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

HighCom Global Security, Inc. Blog

HighCom Global Security, Inc. News:

HighCom Global Security Provides Q2, FH 2017 Financial Update

HighCom Global Security Issues Update on Product Technology Advances

HighCom Global Security Introduces New CEO and Board of Directors as Part of Globally Focused Restructuring Plan

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.10, even for the day. The stock’s average daily volume over the past 60 days is 12,930 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

NetworkNewsWire Releases Exclusive Audio Interview with Algae Dynamics Corp. (ADYNF)

Algae Dynamics Corp. (ADYNF) Engages NetworkNewsWire for Corporate Communications Solutions

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Wolf of Penny Stocks
(STTH) +234.95%

2.

StockMarketWatch
(QURE) +60.08%

3.

Stock Beast
(IMMY) +28.77%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251